Epithelial-mesenchymal transition (EMT), a critical process of cancer invasion and metastasis, is associated with stemness property of cancer cells. Though Oct4 and Nanog are homebox transcription factors essential to the self-renewal of stem cells and are expressed in several cancers, the role of Oct4/Nanog signaling in tumorigenesis is still elusive. Here microarray and quantitative real-time PCR analysis showed a parallel, elevated expression of Oct4 and Nanog in lung adenocarcinoma (LAC). Ectopic expressions of Oct4 and Nanog in LACs increased the percentage of CD133-expressing subpopulation and sphere formation, enhanced drug resistance, and promoted EMT. Ectopic expressions of Oct4 and Nanog activated Slug and enhanced the tumorinitiating capability of LAC. Furthermore, double knockdown of Oct4 and Nanog suppressed the expression of Slug, reversed the EMT process, blocked the tumorigenic and metastatic ability, and greatly improved the mean survival time of transplanted immunocompromised mice. The immunohistochemical analysis demonstrated that expressions of Oct4, Nanog, and Slug were present in high-grade LAC, and triple positivity of Oct4/Nanog/ Slug indicated a worse prognostic value of LAC patients. Our results support the notion that the Oct4/Nanog signaling controls epithelial-mesenchymal transdifferentiation, regulates tumor-initiating ability, and promotes metastasis of LAC. Cancer Res; 70(24); 10433-44. Ó2010 AACR.

The question of whether the metal chalcogenides (phosphides) that have been acknowledged to be efficient materials for bifunctional electrocatalysts really perform as the active species or just “pre-catalysts” has been debated. Herein, a series of operando measurements, including in situ X-ray absorption spectroscopy, liquid-phase transmission electron microscopy, and in situ Raman spectroscopy, were conducted to unravel in real time the structural and chemical stability of P-substituted CoSe2 electrocatalysts under both hydrogen and oxygen evolution reactions (HER and OER, respectively) in an alkaline electrolyte. It can be conclusively revealed that, in an alkaline electrolyte, the P-substituted CoSe2 electrocatalyst was acting as the “pre-catalyst” rather than the real reactive species. The introduction of phosphorus is speculated to generate more vacancies or defects around Co cations in the initial CoSe2 and considerably facilitates the structural transformation into the “real reactive species”, such as metallic cobalt (for HER) and cobalt oxyhydroxide (for OER).

DM and IGT subjects had an impaired CAF independent of other cardiovascular risk factors. The risk of altered CAF is not apparent in subjects with isolated IFG.